Quark Biosciences is a biotechnology company based in Taiwan. We develops innovative tests, based on the domain knowledge of either in-house staff scientists or co-development collaborations based on NextAmp™ Analysis System, creating ready-to-use products to partners for service to end-users. QuarkBio was founded in 2012 on the belief that the one-size-fits-all medical approach is obsolete and that emerging needs of precision healthcare solutions needed to be met in ways that would not be financially burdensome to patients. Taking into account each individual’s genetic profile variations, our products provide customers with an extensive spectrum of solutions starting from disease prevention, diagnosis, treatment to prognosis.